https://www.sciencedaily.com/news/health_medicine/multiple_myeloma/ Read the latest news and information about multiple myeloma and related conditions, including potential symptoms, causes and treatments of the disease. en-us Wed, 22 Apr 2026 09:19:32 EDT Wed, 22 Apr 2026 09:19:32 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/multiple_myeloma/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/02/260222085203.htm Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care. Mon, 23 Feb 2026 06:46:07 EST https://www.sciencedaily.com/releases/2026/02/260222085203.htm https://www.sciencedaily.com/releases/2025/12/251226045343.htm Vitamin C doesn’t just belong in skincare products—it works even better when you eat it. Scientists discovered that vitamin C from food travels through the bloodstream into every layer of the skin, boosting collagen and skin renewal. People who ate two vitamin C–packed kiwifruit daily showed thicker, healthier skin. The findings suggest glowing skin really does start from within. Fri, 26 Dec 2025 11:18:28 EST https://www.sciencedaily.com/releases/2025/12/251226045343.htm https://www.sciencedaily.com/releases/2025/12/251210092019.htm Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster increases in proteins linked to neurodegeneration and amyloid buildup. Surprisingly, blood tests detected these changes earlier than PET scans. The results point to obesity as a major, modifiable contributor to Alzheimer’s progression. Wed, 10 Dec 2025 12:23:51 EST https://www.sciencedaily.com/releases/2025/12/251210092019.htm https://www.sciencedaily.com/releases/2025/09/250929054920.htm Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new treatment approach. Mon, 29 Sep 2025 22:12:19 EDT https://www.sciencedaily.com/releases/2025/09/250929054920.htm https://www.sciencedaily.com/releases/2025/04/250409115000.htm Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Now, research reveals a method that uses pulsed infrared light to identify molecular profiles in blood plasma that could indicate the presence of certain common cancers. In this proof-of-concept study, blood plasma from more than 2,000 people was analyzed to link molecular patterns to lung cancer, extrapolating a potential 'cancer fingerprint.' Wed, 09 Apr 2025 11:50:00 EDT https://www.sciencedaily.com/releases/2025/04/250409115000.htm https://www.sciencedaily.com/releases/2025/03/250327141557.htm Researchers reveal critical mechanism behind idiopathic pulmonary fibrosis. Thu, 27 Mar 2025 14:15:57 EDT https://www.sciencedaily.com/releases/2025/03/250327141557.htm https://www.sciencedaily.com/releases/2025/03/250324220621.htm A study has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for detecting abnormal brain beta-amyloid pathology, a hallmark of Alzheimer's disease. Mon, 24 Mar 2025 22:06:21 EDT https://www.sciencedaily.com/releases/2025/03/250324220621.htm https://www.sciencedaily.com/releases/2025/03/250312190952.htm A new study analyzing diet, average plasma sugar levels and cancer prevalence in some 273 vertebrate species showed surprising results. The study found no significant link between diet and plasma sugar levels across nonhuman vertebrate species, suggesting that glucose regulation is likely influenced more by evolutionary and physiological adaptations than diet alone. Birds in particular did not suffer increased cancer rates compared with mammals and reptiles, despite having higher blood glucose levels, which are associated with increased cancer risk in other animals, including humans. Wed, 12 Mar 2025 19:09:52 EDT https://www.sciencedaily.com/releases/2025/03/250312190952.htm https://www.sciencedaily.com/releases/2025/02/250221125544.htm Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy. Fri, 21 Feb 2025 12:55:44 EST https://www.sciencedaily.com/releases/2025/02/250221125544.htm https://www.sciencedaily.com/releases/2025/02/250210132403.htm When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer progression could advance diagnostics and treatment. Mon, 10 Feb 2025 13:24:03 EST https://www.sciencedaily.com/releases/2025/02/250210132403.htm https://www.sciencedaily.com/releases/2025/01/250114125014.htm A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone healing and tumor control. Tue, 14 Jan 2025 12:50:14 EST https://www.sciencedaily.com/releases/2025/01/250114125014.htm https://www.sciencedaily.com/releases/2024/12/241210163409.htm A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk SMM carries a higher likelihood of progression. Tue, 10 Dec 2024 16:34:09 EST https://www.sciencedaily.com/releases/2024/12/241210163409.htm https://www.sciencedaily.com/releases/2024/11/241118170655.htm New research now can identify more proteins, or biomarkers, in blood plasma, including those linked to specific diseases like cancer. By identifying these biomarkers earlier, medical researchers can create better diagnostic tests and drugs that target diseases sooner, improving patient outcomes. Mon, 18 Nov 2024 17:06:55 EST https://www.sciencedaily.com/releases/2024/11/241118170655.htm https://www.sciencedaily.com/releases/2024/11/241101123652.htm Brain disorders like Parkinson's or Alzheimer's Disease start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their disease, but there is currently no way to diagnose brain disorders at those pre-symptomatic stages. Fri, 01 Nov 2024 12:36:52 EDT https://www.sciencedaily.com/releases/2024/11/241101123652.htm https://www.sciencedaily.com/releases/2024/10/241025122721.htm Researchers have found that using non-thermal atmospheric pressure plasma on rotator cuff tears resulted in accelerated healing of the tendon-bone junction with improved strength in comparison to a control group. Fri, 25 Oct 2024 12:27:21 EDT https://www.sciencedaily.com/releases/2024/10/241025122721.htm https://www.sciencedaily.com/releases/2024/10/241010124655.htm Results of the first phase of a Ceramide Ring Trial have just been published, representing a significant landmark in the field of lipidomics. This achievement represents a groundbreaking advance in the establishment of ceramide reference values, plasma lipids involved in such as cardiovascular diseases. Thu, 10 Oct 2024 12:46:55 EDT https://www.sciencedaily.com/releases/2024/10/241010124655.htm https://www.sciencedaily.com/releases/2024/10/241008122345.htm A new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The information it provides can help prevent the tumor from becoming resistant to drugs. Tue, 08 Oct 2024 12:23:45 EDT https://www.sciencedaily.com/releases/2024/10/241008122345.htm https://www.sciencedaily.com/releases/2024/10/241004121850.htm A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma. In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T therapy for multiple myeloma, patients experienced efficacy and safety results similar to those seen in clinical trials, according to new results. Fri, 04 Oct 2024 12:18:50 EDT https://www.sciencedaily.com/releases/2024/10/241004121850.htm https://www.sciencedaily.com/releases/2024/10/241003123114.htm A new study estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission. Thu, 03 Oct 2024 12:31:14 EDT https://www.sciencedaily.com/releases/2024/10/241003123114.htm https://www.sciencedaily.com/releases/2024/09/240918124924.htm Two new papers by a team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also, critically, to predict the conversion from MCI to dementia due to Alzheimer's disease. Moreover, the researchers uncovered microRNA candidate molecular biomarkers that associate with current Amyloid, Tau, and Neurodegeneration (A/T/N) Alzheimer's biomarkers. Wed, 18 Sep 2024 12:49:24 EDT https://www.sciencedaily.com/releases/2024/09/240918124924.htm https://www.sciencedaily.com/releases/2024/09/240911112123.htm The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy was statistically comparable to the frequency of SPMs following other standard-of-care therapies, according to a systematic review and meta-analysis. Wed, 11 Sep 2024 11:21:23 EDT https://www.sciencedaily.com/releases/2024/09/240911112123.htm https://www.sciencedaily.com/releases/2024/09/240909160239.htm RNA is expelled from cells via cell death or active release, and can then find its way into blood plasma. Medical researchers have now developed machine learning models that use these cell-free molecular RNA dregs to diagnose pediatric inflammatory conditions that are difficult to differentiate. The diagnostic tool can accurately determine if a patient has Kawasaki disease (KD), Multisystem Inflammatory Syndrome in Children (MIS-C), a viral infection or a bacterial infection, while simultaneously monitoring the patient's organ health. Mon, 09 Sep 2024 16:02:39 EDT https://www.sciencedaily.com/releases/2024/09/240909160239.htm https://www.sciencedaily.com/releases/2024/07/240726113346.htm Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant limitation: many patients, including those whose cancer goes into full remission, eventually relapse. Researchers report on a technique with the potential to eliminate that problem. Fri, 26 Jul 2024 11:33:46 EDT https://www.sciencedaily.com/releases/2024/07/240726113346.htm https://www.sciencedaily.com/releases/2024/07/240724123023.htm A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new research. Wed, 24 Jul 2024 12:30:23 EDT https://www.sciencedaily.com/releases/2024/07/240724123023.htm https://www.sciencedaily.com/releases/2024/07/240724122957.htm Cell membranes play a crucial role in maintaining the integrity and functionality of cells. However, the mechanisms by which they perform these roles are not yet fully understood. Scientists have used cryo-electron microscopy to observe how lipids and proteins at the plasma membrane interact and react to mechanical stress. This work shows that, depending on conditions, small membrane regions can stabilize various lipids to trigger specific cellular responses. These discoveries confirm the existence of well-organized lipid domains and begin to reveal the role they play in cell survival. Wed, 24 Jul 2024 12:29:57 EDT https://www.sciencedaily.com/releases/2024/07/240724122957.htm https://www.sciencedaily.com/releases/2024/07/240722155109.htm The researchers report the ability of protein 'signatures' to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease, pulmonary fibrosis, and dilated cardiomyopathy. Mon, 22 Jul 2024 15:51:09 EDT https://www.sciencedaily.com/releases/2024/07/240722155109.htm https://www.sciencedaily.com/releases/2024/07/240702135409.htm Researchers show for the first time that engineered human plasma B cells can be used to treat a disease -- specifically leukemia -- in a humanized animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune disorders, and protein deficiency disorders. Tue, 02 Jul 2024 13:54:09 EDT https://www.sciencedaily.com/releases/2024/07/240702135409.htm https://www.sciencedaily.com/releases/2024/07/240701131804.htm Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back. To be able to intervene faster and on a more targeted basis, researchers completed a comprehensive study of this disease at the molecular level. Mon, 01 Jul 2024 13:18:04 EDT https://www.sciencedaily.com/releases/2024/07/240701131804.htm https://www.sciencedaily.com/releases/2024/05/240521124710.htm Researchers have been focusing on non-thermal atmospheric-pressure plasma as a treatment method that can shorten recovery times, such as for tendon repair. Using a helium plasma jet, they demonstrated that irradiation of ruptured Achilles tendons showed accelerated regeneration and increased strength at an earlier stage than if the injury site was not irradiated. Tue, 21 May 2024 12:47:10 EDT https://www.sciencedaily.com/releases/2024/05/240521124710.htm https://www.sciencedaily.com/releases/2024/05/240517164121.htm The sweet-taste receptor might be the first stop in a metabolic surveillance system for sugar. The receptor is also expressed in certain intestinal cells, where it may facilitate glucose absorption and assimilation, as part of this system. A team found that stimulation and inhibition of the sweet receptor helps regulate glucose metabolism in humans and may have implications for managing such metabolic disorders as diabetes. Fri, 17 May 2024 16:41:21 EDT https://www.sciencedaily.com/releases/2024/05/240517164121.htm https://www.sciencedaily.com/releases/2024/03/240325135716.htm New research has found that venetoclax, a medication currently approved for leukemia, has benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers a new avenue of treatment options for the currently incurable disease. Mon, 25 Mar 2024 13:57:16 EDT https://www.sciencedaily.com/releases/2024/03/240325135716.htm https://www.sciencedaily.com/releases/2024/03/240313210231.htm An effective treatment for chronic wounds that does not involve antibiotics, but an ionised gas to activate a wound dressing, has been developed by a team of international scientists. Wed, 13 Mar 2024 21:02:31 EDT https://www.sciencedaily.com/releases/2024/03/240313210231.htm https://www.sciencedaily.com/releases/2024/03/240308123317.htm Researchers have shown that sleep enhances the migratory potential of T cells toward lymph nodes. Fri, 08 Mar 2024 12:33:17 EST https://www.sciencedaily.com/releases/2024/03/240308123317.htm https://www.sciencedaily.com/releases/2024/02/240209134347.htm Researchers around the world share results from a novel model that can provide tailored predictions of how individual patients respond to different therapies. Fri, 09 Feb 2024 13:43:47 EST https://www.sciencedaily.com/releases/2024/02/240209134347.htm https://www.sciencedaily.com/releases/2024/01/240114202019.htm Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple myeloma, according to new research. Sun, 14 Jan 2024 20:20:19 EST https://www.sciencedaily.com/releases/2024/01/240114202019.htm https://www.sciencedaily.com/releases/2023/12/231213112900.htm New research sheds light on the mechanisms how cancer cells evade killing by the immune system. These results open the door to new possible individualized treatments for blood cancers and beyond, involving a critical part of the human body's immune system, the natural killer (NK) cells. Wed, 13 Dec 2023 11:29:00 EST https://www.sciencedaily.com/releases/2023/12/231213112900.htm https://www.sciencedaily.com/releases/2023/10/231025110557.htm A new study shows that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality. Wed, 25 Oct 2023 11:05:57 EDT https://www.sciencedaily.com/releases/2023/10/231025110557.htm https://www.sciencedaily.com/releases/2023/10/231004105202.htm Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer, and multiple myeloma, according to a new study. Obesity has been linked to increased risk for 13 types of cancer in women, and physical activity, independent of body size, lowers risk for some of these cancers.  Until now long-term studies of neighborhood walkability and risk for obesity-related cancer were limited. Wed, 04 Oct 2023 10:52:02 EDT https://www.sciencedaily.com/releases/2023/10/231004105202.htm https://www.sciencedaily.com/releases/2023/09/230929130824.htm Patients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when compared to those without diabetes. In a subgroup analysis, this difference in survival due to diabetes was seen in White patients but not in Black patients, according to a new study. Fri, 29 Sep 2023 13:08:24 EDT https://www.sciencedaily.com/releases/2023/09/230929130824.htm https://www.sciencedaily.com/releases/2023/09/230922110826.htm A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma. Fri, 22 Sep 2023 11:08:26 EDT https://www.sciencedaily.com/releases/2023/09/230922110826.htm https://www.sciencedaily.com/releases/2023/09/230912110147.htm A ground-breaking study has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKC-alpha in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more aggressive and resistant to treatment. Tue, 12 Sep 2023 11:01:47 EDT https://www.sciencedaily.com/releases/2023/09/230912110147.htm https://www.sciencedaily.com/releases/2023/08/230831121640.htm Scientists identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies. Thu, 31 Aug 2023 12:16:40 EDT https://www.sciencedaily.com/releases/2023/08/230831121640.htm https://www.sciencedaily.com/releases/2023/08/230801105024.htm Researchers have identified plasma protein-based biomarkers capable of identifying adolescents at risk of developing mental health issues. Tue, 01 Aug 2023 10:50:24 EDT https://www.sciencedaily.com/releases/2023/08/230801105024.htm https://www.sciencedaily.com/releases/2023/05/230531101947.htm Consuming nutritious food can improve metabolic health and delay aging. But what are the appropriate quantities of dietary macronutrients that can help achieve this? To answer this, researchers fed isocaloric diets with varying amounts of protein to young and middle-aged male mice. They found that the mice were metabolically healthier when fed moderate-protein diets. These findings could provide valuable insights into developing nutritional interventions and improving metabolic health in people. Wed, 31 May 2023 10:19:47 EDT https://www.sciencedaily.com/releases/2023/05/230531101947.htm https://www.sciencedaily.com/releases/2023/03/230322190857.htm Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. Researchers have now described a distinct and novel subset of memory B cells that predict long-lived antibody responses to influenza vaccination in humans. These effector memory B cells appear to be poised for a rapid serum antibody response upon secondary challenge one year later. Wed, 22 Mar 2023 19:08:57 EDT https://www.sciencedaily.com/releases/2023/03/230322190857.htm https://www.sciencedaily.com/releases/2023/02/230221113018.htm A new analysis shows how convalescent plasma can be used to prevent hospitalizations and ultimately save lives, both for COVID-19 and for the next viral pandemic that inevitably arrives. Tue, 21 Feb 2023 11:30:18 EST https://www.sciencedaily.com/releases/2023/02/230221113018.htm https://www.sciencedaily.com/releases/2023/01/230126124425.htm Chemists designed a bottlebrush-shaped nanoparticle that can be loaded with multiple drugs, in ratios that can be easily controlled. Using these particles, the researchers calculated and delivered the optimal ratio of three cancer drugs used to treat multiple myeloma. Thu, 26 Jan 2023 12:44:25 EST https://www.sciencedaily.com/releases/2023/01/230126124425.htm https://www.sciencedaily.com/releases/2022/12/221222123117.htm Researchers have demonstrated that people suffering from blood cancer have a good immune response to COVID-19 vaccinations. Vaccination protects patients with B-cell lymphoma and multiple myeloma against severe illness from COVID-19. Some patients even form highly potent antibodies. Thu, 22 Dec 2022 12:31:17 EST https://www.sciencedaily.com/releases/2022/12/221222123117.htm https://www.sciencedaily.com/releases/2022/12/221221154658.htm Researchers have discovered unique patterns of blood plasma proteins in critically ill patients that may help develop a more personalized approach to treating severe COVID-19. Wed, 21 Dec 2022 15:46:58 EST https://www.sciencedaily.com/releases/2022/12/221221154658.htm https://www.sciencedaily.com/releases/2022/12/221220113003.htm In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An agent that inhibits the activity of this enzyme reduced cancer-related bone loss and the number of bone metastases in multiple myeloma and in lung and breast cancer models in mice. Tue, 20 Dec 2022 11:30:03 EST https://www.sciencedaily.com/releases/2022/12/221220113003.htm https://www.sciencedaily.com/releases/2022/12/221211082744.htm A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials. Sun, 11 Dec 2022 08:27:44 EST https://www.sciencedaily.com/releases/2022/12/221211082744.htm https://www.sciencedaily.com/releases/2022/11/221128101229.htm Researchers used an innovative proteomics method to identify four proteins in the blood that are associated with critical pathogenesis in patients with COVID-19. Mon, 28 Nov 2022 10:12:29 EST https://www.sciencedaily.com/releases/2022/11/221128101229.htm https://www.sciencedaily.com/releases/2022/11/221118114845.htm A novel artificial intelligence blood testing technology has been used to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people. Fri, 18 Nov 2022 11:48:45 EST https://www.sciencedaily.com/releases/2022/11/221118114845.htm https://www.sciencedaily.com/releases/2022/11/221104100247.htm Researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards. Fri, 04 Nov 2022 10:02:47 EDT https://www.sciencedaily.com/releases/2022/11/221104100247.htm https://www.sciencedaily.com/releases/2022/10/221028140723.htm Vaccines work their magic by effectively creating immune cells that are long lived, often for over decades. These immune cells create both a protective barrier that can prevent or minimize re-infection and a memory that allows us to recognize an old invader like a virus and to kill it before it causes disease. The antibody in our blood that is the barrier is made by 'long lived plasma cells' and while the importance of these cells has always been know, how and when they are generated following a vaccination has remained a mystery. Until now. A research team has shown in real time how immune memory cells are stored in the bone marrow at around one single cell per hour for several weeks after immunization. Fri, 28 Oct 2022 14:07:23 EDT https://www.sciencedaily.com/releases/2022/10/221028140723.htm https://www.sciencedaily.com/releases/2022/10/221012163437.htm Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review paper examines the potential drug-drug interactions (DDIs) between Paxlovid and commonly used cardiovascular medications, as well as potential options to mitigate severe adverse effects. Wed, 12 Oct 2022 16:34:37 EDT https://www.sciencedaily.com/releases/2022/10/221012163437.htm https://www.sciencedaily.com/releases/2022/09/220913110445.htm Researchers used extensive single-cell analysis to create a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung cancers, revealing new roles for these immune cells in cancer development and immunotherapy responses. Tue, 13 Sep 2022 11:04:45 EDT https://www.sciencedaily.com/releases/2022/09/220913110445.htm https://www.sciencedaily.com/releases/2022/09/220906102025.htm New CT technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional CT, according to a new study. Tue, 06 Sep 2022 10:20:25 EDT https://www.sciencedaily.com/releases/2022/09/220906102025.htm https://www.sciencedaily.com/releases/2022/09/220901135951.htm Researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time -- they are meant to enhance the immune system's destruction of tumor cells. Thu, 01 Sep 2022 13:59:51 EDT https://www.sciencedaily.com/releases/2022/09/220901135951.htm https://www.sciencedaily.com/releases/2022/07/220719102321.htm While Omicron variants of the pandemic coronavirus ratchet up immune evasion, a new study suggests current boosters intensify protections against serious infection. Tue, 19 Jul 2022 10:23:21 EDT https://www.sciencedaily.com/releases/2022/07/220719102321.htm